Clinical Trial

Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis

Name: Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis — clinical trial record (NCT07503587)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PPF

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study is open to adults with PPF . The main objective is to evaluate of the efficacy and the secondary objective is to evaluate the safety and pharmacokinetic.

Trial Details

NCT Number	NCT07503587
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	Progressive Pulmonary Fibrosis
Enrollment	378 participants
Start Date	2026-04-05
Primary Completion	2028-12-30 (estimated)
Study Completion	2029-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-31